Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group.

CONTEXT Studies on meningococcal disease in large urban communities have rarely been performed and are usually based on passive epidemiologic surveillance. Active surveillance may provide new insights. OBJECTIVES To determine epidemiologic, clinical, and bacteriological characteristics and predictors of dismal prognosis (death and sequelae) in meningococcal disease. DESIGN Prospective, population-based study. SETTING All the acute care hospitals (n = 24) in Barcelona, Spain. PATIENT The 643 patients whose conditions were diagnosed from 1987 through 1992 were detected by 2 active surveillance methods. OUTCOME MEASURES Incidence and notification to Public Health Service. Clinical and bacteriological features were determined. Dismal prognosis predictors were determined by logistic regression. RESULTS Average annual incidence was 6.41 per 100,000 inhabitants, with no clear trend of change (P = .08). Sensitivity of the Public Health Service surveillance system was 69.1%. Children younger than 10 years from the inner city were at higher risk than those from the highest income district (relative risk, 3.00; 95% confidence interval [CI], 1.84-5.06). Increasing annual incidence of serogroup C (0.82-1.29/100,000; P = .008) and decreasing incidence of serogroup B (5.11-2.82/100,000; P = .004) was noted. Average annual mortality was 0.40 per 100,000 inhabitants, while the annual average potential years of life lost was 18 per 100,000 inhabitants. Overall case-fatality rate was 6.4%. Independent predictors of death were hemorrhagic diathesis (odds ratio [OR], 63; 95% CI, 21-194), focal neurologic signs (OR, 10; 95% CI, 3-30), and age 60 years or older (OR, 6; 95% CI, 2-17), whereas preadmission antibiotic therapy was associated with favorable outcome (OR, 0.07; 95% CI, 0.02-0.3). Four percent of survivors presented with sequelae. Independent predictors of sequelae were hemorrhagic diathesis (OR, 21; 95% CI, 3-131), focal neurologic signs (OR, 16; 95% CI, 5-53), age 60 years or older (OR, 7; 95% CI, 2-26), and age between 15 and 59 years (OR, 5; 95% CI, 2-14), whereas preadmission antibiotic therapy had a protective effect (OR, 0.2; 95% CI, 0.04-0.5). CONCLUSIONS Active epidemiologic surveillance significantly improved detection of cases and allowed us to observe that meningococcal disease still causes much morbidity and mortality, especially among children living in the inner city. Hemorrhagic diathesis, focal neurologic signs, and age were independent predictors of dismal prognosis, whereas preadmission antibiotic therapy had a protective effect.

[1]  R. Pill,et al.  Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information , 1998, BMJ.

[2]  A. Schuchat,et al.  Bacterial Meningitis in the United States in 1995 , 1997 .

[3]  J. Caylà,et al.  Prognostic Factors in Meningococcal Disease: Development of a Bedside Predictive Model and Scoring System , 1997 .

[4]  J. Caylà,et al.  Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. , 1997, JAMA.

[5]  P. Collignon,et al.  New guidelines for management and prevention of meningococcal disease in Australia , 1997, The Medical journal of Australia.

[6]  A. Schuchat,et al.  Meningococcal disease in Los Angeles County, California, and among men in the county jails. , 1996, The New England journal of medicine.

[7]  D. Stephens,et al.  Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study , 1995, Annals of Internal Medicine.

[8]  J. Caylà,et al.  Sore throat, antibiotics, and progression to meningococcal disease , 1995, The Lancet.

[9]  J. Hockin,et al.  The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. , 1995, JAMA.

[10]  J. Vázquez,et al.  Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship? , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Slater,et al.  Forty years of meningococcal disease in Israel: 1951-1990. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  E. Ford,et al.  Surveillance for diabetes mellitus--United States, 1980-1989; and Laboratory-based surveillance for meningococcal disease in selected areas--United States, 1989-1991 , 1993 .

[13]  R. Schneider Meningococcal infections: Reducing the case fatality rate by giving penicillin before admission to hospital , 1993 .

[14]  H T Sørensen,et al.  Early treatment of meningococcal disease. , 1992, BMJ.

[15]  N. Begg Reducing mortality from meningococcal disease. , 1992, BMJ.

[16]  K. Cartwright,et al.  Early treatment with parenteral penicillin in meningococcal disease. , 1992, BMJ.

[17]  K. Cartwright,et al.  Mortality in meningococcal disease. , 1992, BMJ.

[18]  M. H. Terry,et al.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. , 1991, NIPH annals.

[19]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[20]  A. Halstensen,et al.  Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway , 1991, The Lancet.

[21]  R. Pinner,et al.  Meningococcal Disease in the United States—1986 , 1991 .

[22]  A. Hightower,et al.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.

[23]  L G Escobedo,et al.  Behavioral Risk Factor Surveillance, 1988. , 1990, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[24]  H. A. Kahn,et al.  Statistical Methods in Epidemiology , 1989 .

[25]  K. Bøvre,et al.  Meningococcal disease in Norway 1981-1982, with focus on severe septicemia and death. Epidemiological trends and relation of cases to some health service factors. , 1989, NIPH annals.

[26]  D. Allan,et al.  Paediatric coma scale. , 1989, Nursing times.

[27]  B. Schwartz,et al.  Global epidemiology of meningococcal disease , 1989, Clinical Microbiology Reviews.

[28]  P. Brandtzaeg,et al.  Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. , 1989, The Journal of infectious diseases.

[29]  D. Talan,et al.  Role of empiric parenteral antibiotics prior to lumbar puncture in suspected bacterial meningitis: state of the art. , 1988, Reviews of infectious diseases.

[30]  J. Poolman,et al.  Whole‐cell ELISA for typing Neisseria meningitidis with monoclonal antibodies , 1987 .

[31]  J. A. García de Jalón,et al.  Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations , 1987, Epidemiology and Infection.

[32]  R. Fallon MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPE , 1986, The Lancet.

[33]  J. Stuart,et al.  AN OUTBREAK OF MENINGOCOCCAL DISEASE IN GLOUCESTERSHIRE , 1986, The Lancet.

[34]  Charles C. Ragin,et al.  Software for Sociologists: Statistical Analysis on the IBM PC@@@SPSS/PC + for the IBM PC/XT/AT. , 1986 .

[35]  H. Zanen,et al.  The incidence of bacterial meningitis in the Netherlands--a comparison of three registration systems, 1977-1982. , 1985, The Journal of infection.

[36]  C. Frasch,et al.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. , 1985, Reviews of infectious diseases.

[37]  P. De Wals,et al.  Validity of the recording of meningococcal disease according to various sources of information. , 1984, The Journal of infection.

[38]  N. Rasmussen,et al.  875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series. , 1983, The Journal of infection.

[39]  J. Hendley,et al.  Clinical and Serological Evaluation of a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W135 , 1982, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  K. Nelson,et al.  Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976. , 1980, Reviews of infectious diseases.

[41]  R. Marier,et al.  The reporting of communicable diseases. , 1977, American journal of epidemiology.

[42]  M. Goldacre,et al.  Completeness of statutory notification for acute bacterial meningitis. , 1976, British medical journal.

[43]  R. Perkins,et al.  Acute bacterial meningitis: an analysis of factors influencing prognosis , 1975, The American journal of the medical sciences.

[44]  B. Jennett,et al.  Assessment of coma and impaired consciousness. A practical scale. , 1974, Lancet.

[45]  C. O'callaghan,et al.  Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin Substrate , 1972, Antimicrobial Agents and Chemotherapy.

[46]  M. Artenstein,et al.  HUMAN IMMUNITY TO THE MENINGOCOCCUS : III. PREPARATION AND IMMUNOCHEMICAL PROPERTIES OF THE GROUP A, GROUP B, AND GROUP C MENINGOCOCCAL POLYSACCHARIDES , 1969 .

[47]  P. Arling,et al.  Penicillin in the Treatment of Meningitis , 1944 .

[48]  P. Long,et al.  The Treatment of Meningococcic Meningitis With Sulfanilamide: Preliminary Report , 1937 .

[49]  K. Alestig,et al.  Incidence, serogroups and case-fatality rate of invasive meningococcal infections in a Swedish region 1975-1989. , 1992, Scandinavian journal of infectious diseases.

[50]  A. Halstensen,et al.  Case fatality of meningococcal disease in western Norway. , 1987, Scandinavian journal of infectious diseases.

[51]  D. Mackey,et al.  Skin clues in the diagnosis of life-threatening infections. , 1986, Reviews of infectious diseases.

[52]  H. Peltola Meningococcal disease: still with us. , 1983, Reviews of infectious diseases.

[53]  D. Hosmer,et al.  A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.

[54]  N. Vedros Chapter XI Serology of the Meningococcus , 1978 .

[55]  Meningococcal disease. Secondary attack rate and chemoprophylaxis in the United States, 1974. , 1976, JAMA.